CARD10
Basic information
Region (hg38): 22:37490362-37519542
Links
Phenotypes
GenCC
Source:
- immunodeficiency 89 and autoimmunity (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency 89 and autoimmunity | AR | Allergy/Immunology/Infectious | The condition may involve susceptibility to infections (including involving pulmonary sequelae), and and prophylactic measures, as well as early and aggressive treatment of infections may be beneficial | Allergy/Immunology/Infectious | 32238915 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CARD10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 20 | ||||
missense | 51 | 57 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 2 | 5 | |||
non coding | 4 | |||||
Total | 0 | 0 | 55 | 10 | 18 |
Variants in CARD10
This is a list of pathogenic ClinVar variants found in the CARD10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-37491163-G-T | CARD10-related disorder | Uncertain significance (Feb 05, 2024) | ||
22-37491181-C-T | CARD10-related disorder | Benign (Sep 17, 2019) | ||
22-37491186-T-G | not specified | Uncertain significance (Apr 13, 2022) | ||
22-37491199-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
22-37491203-C-G | CARD10-related disorder | Uncertain significance (Feb 05, 2024) | ||
22-37491239-G-A | not specified | Uncertain significance (Sep 27, 2021) | ||
22-37491245-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
22-37491246-C-G | Likely benign (Mar 01, 2022) | |||
22-37491799-G-A | CARD10-related disorder | Benign (Dec 31, 2019) | ||
22-37491811-C-G | not specified | Uncertain significance (Dec 01, 2022) | ||
22-37491831-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
22-37491855-G-T | not specified | Uncertain significance (Feb 13, 2024) | ||
22-37492481-G-A | not specified | Uncertain significance (Jun 11, 2024) | ||
22-37492533-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
22-37492707-G-A | not specified | Uncertain significance (Mar 20, 2024) | ||
22-37492712-G-A | not specified | Uncertain significance (Apr 29, 2024) | ||
22-37492762-C-T | CARD10-related disorder | Benign (Feb 28, 2019) | ||
22-37492785-T-C | not specified | Uncertain significance (Feb 07, 2023) | ||
22-37492794-G-A | Primary open angle glaucoma | risk factor (Mar 29, 2016) | ||
22-37492809-C-G | CARD10-related disorder | Likely benign (Jul 16, 2019) | ||
22-37495539-C-G | not specified | Uncertain significance (Sep 07, 2022) | ||
22-37495539-C-T | not specified | Uncertain significance (Jul 27, 2021) | ||
22-37495549-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
22-37495769-T-G | not specified | Uncertain significance (Apr 04, 2024) | ||
22-37495781-C-A | not specified | Uncertain significance (Feb 02, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CARD10 | protein_coding | protein_coding | ENST00000403299 | 20 | 29150 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00226 | 0.998 | 125685 | 0 | 63 | 125748 | 0.000251 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.20 | 465 | 619 | 0.751 | 0.0000408 | 6427 |
Missense in Polyphen | 78 | 124.16 | 0.6282 | 1235 | ||
Synonymous | 0.604 | 250 | 262 | 0.953 | 0.0000153 | 2174 |
Loss of Function | 4.71 | 15 | 51.4 | 0.292 | 0.00000259 | 571 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000754 | 0.000726 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000112 | 0.000109 |
Finnish | 0.0000489 | 0.0000462 |
European (Non-Finnish) | 0.000308 | 0.000299 |
Middle Eastern | 0.000112 | 0.000109 |
South Asian | 0.000203 | 0.000196 |
Other | 0.000685 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Activates NF-kappa-B via BCL10 and IKK.;
- Pathway
- NF-kappa B signaling pathway - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.0937
Intolerance Scores
- loftool
- 0.659
- rvis_EVS
- -1.15
- rvis_percentile_EVS
- 6.32
Haploinsufficiency Scores
- pHI
- 0.125
- hipred
- Y
- hipred_score
- 0.762
- ghis
- 0.623
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.911
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Card10
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- activation of NF-kappaB-inducing kinase activity;regulation of apoptotic process;protein-containing complex assembly;negative regulation of cell migration involved in sprouting angiogenesis;positive regulation of protein localization to nucleus
- Cellular component
- cytoplasm;CBM complex
- Molecular function
- protein binding;receptor signaling complex scaffold activity